Frank Calcagno
Pediatrics · Gresham, ORNPI 1356331847
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 27.2% of the total. Reporting peaked in 2019 at $354 and has fallen 58.7% since, to $146 in 2025. Among pediatrics clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 64 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$347
- Sanofi Pasteur Inc.$227
- Merck$173
- Ironshore Pharmaceuticals Inc.$115
- GSK$88
- Shire North American Group Inc$60
- plus $262 from 10 others
Across 490 payments — averaging $2938.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$357K
- Bausch Health US, LLC$282K
- Sanofi Pasteur Inc.$281K
- GSK$121K
- Merck$75K
- Astute Medical, Inc.$57K
- plus $266K from 15 others
What the payments were for
- Food & beverage$1,273100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 16 | $347 |
| Sanofi Pasteur Inc. | 10 | $227 |
| Merck | 12 | $173 |
| Ironshore Pharmaceuticals Inc. | 6 | $115 |
| GSK | 5 | $88 |
| Shire North American Group Inc | 3 | $60 |
| Pfizer | 2 | $46 |
| Bausch Health US, LLC | 1 | $45 |
| Seqirus USA Inc | 2 | $37 |
| Corium, LLC | 1 | $28 |
| Genentech, Inc. | 1 | $25 |
| Alk-abello, Inc | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| AstraZeneca | 1 | $15 |
How this compares
$1,273 in reported general payments places this provider in the 90th percentile of 403 pediatrics providers in Oregon.
Other pediatrics in Gresham
- Sydmarie BiseniusGresham$928
- June WuGresham$705
- Jacob HendersonPortland$29K
- Meganne LeachPortland$14K
- Christopher PattonGrants Pass$9K
- Galena KolchuginaCorvallis$6K
- Paul HorowitzPortland$5K
- Sarah ViallPortland$4K
- Resa BradeenHappy Valley$4K
- Richard TaylorPortland$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.